Jerry Muhammad

1.2k total citations · 1 hit paper
5 papers, 872 citations indexed

About

Jerry Muhammad is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Jerry Muhammad has authored 5 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Jerry Muhammad's work include Inflammatory mediators and NSAID effects (2 papers), Hepatitis C virus research (2 papers) and Estrogen and related hormone effects (2 papers). Jerry Muhammad is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Hepatitis C virus research (2 papers) and Estrogen and related hormone effects (2 papers). Jerry Muhammad collaborates with scholars based in United Kingdom and United States. Jerry Muhammad's co-authors include Yan Zhang, Ben S. Zweifel, Peter C. Isakson, Jaime L. Masferrer, Carol M. Koboldt, Karen Seibert, John J. Talley, Chris Smith, Jennifer S. Trigg and James K. Gierse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Jerry Muhammad

5 papers receiving 835 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological analysis of cyclooxygenase-1 in inflammation

1998 713 citations Chris Smith, Yan Zhang et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jerry Muhammad United Kingdom	4	522	184	153	148	144	5	872
Maria R. Panara Italy	15	838 1.6×	180 1.0×	278 1.8×	111 0.8×	215 1.5×	34	1.3k
Giovanna Santini Italy	12	419 0.8×	265 1.4×	146 1.0×	91 0.6×	136 0.9×	18	884
Jianmin Fu United States	5	604 1.2×	185 1.0×	208 1.4×	144 1.0×	140 1.0×	6	921
Michael A. Trevethick United Kingdom	19	377 0.7×	376 2.0×	89 0.6×	359 2.4×	79 0.5×	36	1.2k
Johan Beetens Belgium	17	182 0.3×	221 1.2×	114 0.7×	159 1.1×	62 0.4×	39	829
J.E. Tateson United Kingdom	11	379 0.7×	339 1.8×	163 1.1×	263 1.8×	142 1.0×	17	1.1k
W. McKnight Canada	12	404 0.8×	108 0.6×	186 1.2×	231 1.6×	35 0.2×	14	791
Gustav Graff United States	20	211 0.4×	369 2.0×	142 0.9×	113 0.8×	80 0.6×	35	1.0k
Riyaz Mohamed United States	21	222 0.4×	480 2.6×	65 0.4×	57 0.4×	150 1.0×	43	1.2k
Yusaku Komoike Japan	15	301 0.6×	93 0.5×	74 0.5×	70 0.5×	40 0.3×	21	579

Countries citing papers authored by Jerry Muhammad

Since Specialization

Citations

This map shows the geographic impact of Jerry Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Muhammad more than expected).

Fields of papers citing papers by Jerry Muhammad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Muhammad. The network helps show where Jerry Muhammad may publish in the future.

Co-authorship network of co-authors of Jerry Muhammad

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Muhammad. A scholar is included among the top collaborators of Jerry Muhammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Muhammad. Jerry Muhammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Symons, Kent T., Mark E. Massari, John V. Anzola, et al.. (2010). Pharmacological Characterization of KLYP961, a Dual Inhibitor of Inducible and Neuronal Nitric-Oxide Synthases. Journal of Pharmacology and Experimental Therapeutics. 336(2). 468–478. 12 indexed citations

2.

McGuigan, Christopher, Karolina Madela, Arnaud Gilles, et al.. (2010). Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus. Bioorganic & Medicinal Chemistry Letters. 20(16). 4850–4854. 73 indexed citations

3.

Hutchins, J., Chia‐Chi Chang, Elena Gorovits, et al.. (2009). In Vitro Activity and In Vivo Pharmacokinetics of Highly Potent Phosphoramidate Nucleoside Analogue Inhibitors of Hepatitis C NS5B. Antiviral Research. 82(2). A28–A28. 2 indexed citations

4.

Gierse, James K., Yan Zhang, William F. Hood, et al.. (2005). Valdecoxib: Assessment of Cyclooxygenase-2 Potency and Selectivity. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1206–1212. 72 indexed citations

5.

Smith, Chris, Yan Zhang, Carol M. Koboldt, et al.. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proceedings of the National Academy of Sciences. 95(22). 13313–13318. 713 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact